<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37475124</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-2619</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>The Lancet. Respiratory medicine</Title><ISOAbbreviation>Lancet Respir Med</ISOAbbreviation></Journal><ArticleTitle>Mitigating neurological, cognitive, and psychiatric sequelae of COVID-19-related critical illness.</ArticleTitle><Pagination><StartPage>726</StartPage><EndPage>738</EndPage><MedlinePgn>726-738</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2213-2600(23)00238-2</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-2600(23)00238-2</ELocationID><Abstract><AbstractText>Despite advances in the treatment and mitigation of critical illness caused by infection with SARS-CoV-2, millions of survivors have a devastating, post-acute infection syndrome known as long COVID. A large proportion of patients with long COVID have nervous system dysfunction, which is also seen in the distinct but overlapping condition of post-intensive care syndrome (PICS), putting survivors of COVID-19-related critical illness at high risk of long-lasting morbidity affecting multiple organ systems and, as a result, engendering measurable deficits in quality of life and productivity. In this Series paper, we discuss neurological, cognitive, and psychiatric sequelae in patients who have survived critical illness due to COVID-19. We review current knowledge of the epidemiology and pathophysiology of persistent neuropsychological impairments, and outline potential preventive strategies based on safe, evidence-based approaches to the management of pain, agitation, delirium, anticoagulation, and ventilator weaning during critical illness. We highlight priorities for current and future research, including possible therapeutic approaches, and offer considerations for health services to address the escalating health burden of long COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pandharipande</LastName><ForeName>Pratik</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Division of Anesthesiology Critical Care Medicine, Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: pratik.pandharipande@vumc.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams Roberson</LastName><ForeName>Shawniqua</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Departments of Neurology and Biomedical Engineering, Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrison</LastName><ForeName>Fiona E</ForeName><Initials>FE</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Jo Ellen</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center, Vanderbilt University Medical Center, Nashville, TN, USA; Tennessee Valley Veteran's Affairs Geriatric Research Education Clinical Center, VA Tennessee Valley Healthcare System, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bastarache</LastName><ForeName>Julie A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ely</LastName><ForeName>E Wesley</ForeName><Initials>EW</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center, Vanderbilt University Medical Center, Nashville, TN, USA; Tennessee Valley Veteran's Affairs Geriatric Research Education Clinical Center, VA Tennessee Valley Healthcare System, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 AG072030</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM120484</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG075341</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Respir Med</MedlineTA><NlmUniqueID>101605555</NlmUniqueID><ISSNLinking>2213-2600</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Respir Med. 2023 Aug;11(8):667-668. doi: 10.1016/S2213-2600(23)00232-1</RefSource><PMID Version="1">37475126</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of interests EWE and SWR have submitted a grant proposal to study the effects of baricitinib on long COVID. The other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>21</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>20</Day><Hour>23</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37475124</ArticleId><ArticleId IdType="mid">NIHMS1939944</ArticleId><ArticleId IdType="pmc">PMC10706757</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(23)00238-2</ArticleId><ArticleId IdType="pii">S2213-2600(23)00238-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO. WHO Coronavirus (COVID-19) Dashboard. 2023. https://covid19.who.int (accessed July 1, 2023).</Citation></Reference><Reference><Citation>Suthar AB, Wang J, Seffren V, Wiegand RE, Griffing S, Zell E. Public health impact of covid-19 vaccines in the US: observational study. BMJ 2022; 377: e069317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9044401</ArticleId><ArticleId IdType="pubmed">35477670</ArticleId></ArticleIdList></Reference><Reference><Citation>Admon AJ, Iwashyna TJ, Kamphuis LA, et al. Assessment of symptom, disability, and financial trajectories in patients hospitalized for COVID-19 at 6 months. JAMA Netw Open 2023; 6: e2255795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9929698</ArticleId><ArticleId IdType="pubmed">36787143</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, McAuley H, Harrison EM, et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med 2021; 9: 1275&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuzuki S, Miyazato Y, Terada M, Morioka S, Ohmagari N, Beutels P. Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients. Health Qual Life Outcomes 2022; 20: 125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388960</ArticleId><ArticleId IdType="pubmed">35986269</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Sillett R, Zhu L, et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry 2022; 9: 815&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023; 21: 133&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki A, Putrino D. Why we need a deeper understanding of the pathophysiology of long COVID. Lancet Infect Dis 2023; 23: 393&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9928485</ArticleId><ArticleId IdType="pubmed">36967698</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med 2022; 28: 911&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Marra A, Pandharipande PP, Girard TD, et al. Co-occurrence of post-intensive care syndrome problems among 406 survivors of critical illness. Crit Care Med 2018; 46: 1393&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6095801</ArticleId><ArticleId IdType="pubmed">29787415</ArticleId></ArticleIdList></Reference><Reference><Citation>Liou A, Schweickert WD, Files DC, Bakhru RN. A survey to assess primary care physician awareness of complications following critical illness. J Intensive Care Med 2023; published online March 27. 10.1177/08850666231164303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/08850666231164303</ArticleId><ArticleId IdType="pubmed">36972501</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh SJ, Baldwin MM, Daynes E, et al. Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation. Lancet Respir Med 2023; published online May 19. 10.1016/S2213-2600(23)00159-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00159-5</ArticleId><ArticleId IdType="pmc">PMC10198676</ArticleId><ArticleId IdType="pubmed">37216955</ArticleId></ArticleIdList></Reference><Reference><Citation>Parotto M, Gy&#xf6;ngy&#xf6;si M, Howe K, et al. Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations. Lancet Respir Med 2023; published online July 17. 10.1016/S2213-2600(23)00239-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00239-4</ArticleId><ArticleId IdType="pubmed">37475125</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA 2023; 329: 1934&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Department of Health and Human Services. What is long COVID?
2020. https://www.covid.gov/longcovid/definitions (accessed June 11, 2023).</Citation></Reference><Reference><Citation>Department of Health and Human Services. National research action plan on long COVID. August
2022. https://www.covid.gov/assets/files/National-Research-Action-Plan-on-Long-COVID-08012022.pdf (accessed July 1, 2023).</Citation></Reference><Reference><Citation>WHO. A clinical case definition of post COVID-19 condition by a Delphi consensus. Oct
6, 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (accessed July 1, 2023).</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN), and Royal College of General Practitioners (RCGP). COVID-19 rapid guideline: managing the long-term effects of COVID-19. Nov
3, 2022. https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742 (accessed July 1, 2023).</Citation></Reference><Reference><Citation>Wulf Hanson S, Abbafati C, Aerts JG, et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA 2022; 328: 1604&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 2022; 604: 697&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Campion JY, Dudouet P, et al. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging 2021; 48: 2823&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Siow I, Lee KS, Zhang JJY, Saffari SE, Ng A. Encephalitis as a neurological complication of COVID-19: a systematic review and meta-analysis of incidence, outcomes, and predictors. Eur J Neurol 2021; 28: 3491&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8239820</ArticleId><ArticleId IdType="pubmed">33982853</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkowska-Zapa&#x142;a M, Suski M, Szatanek R, et al. Human monocyte subsets exhibit divergent angiotensin I-converting activity. Clin Exp Immunol 2015; 181: 126&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4469162</ArticleId><ArticleId IdType="pubmed">25707554</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander AL, Mills AJ, Kelley M, et al. Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol Neuroimmunol Neuroinflamm 2022; 9: e1146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Balcom EF, Nath A, Power C. Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease. Brain 2021; 144: 3576&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8719840</ArticleId><ArticleId IdType="pubmed">34398188</ArticleId></ArticleIdList></Reference><Reference><Citation>Soudry Y, Lemogne C, Malinvaud D, Consoli SM, Bonfils P. Olfactory system and emotion: common substrates. Eur Ann Otorhinolaryngol Head Neck Dis 2011; 128: 18&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">21227767</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Quan L, Chavarro JE, et al. Associations of depression, anxiety, worry, perceived stress, and loneliness prior to infection with risk of post-COVID-19 conditions. JAMA Psychiatry 2022; 79: 1081&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9453634</ArticleId><ArticleId IdType="pubmed">36069885</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere JJ, Serafini RA, Pryce KD, et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci Transl Med 2022; 14: eabq3059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong M, Ocwieja KE, Han D, et al. Direct SARS-CoV-2 infection of the human inner ear may underlie COVID-19-associated audiovestibular dysfunction. Commun Med (Lond) 2021; 1: 44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8633908</ArticleId><ArticleId IdType="pubmed">34870285</ArticleId></ArticleIdList></Reference><Reference><Citation>Limphaibool N, Iwanowski P, Holstad MJV, Kobylarek D, Kozubski W. Infectious etiologies of parkinsonism: pathomechanisms and clinical implications. Front Neurol 2019; 10: 652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6593078</ArticleId><ArticleId IdType="pubmed">31275235</ArticleId></ArticleIdList></Reference><Reference><Citation>Merello M, Bhatia KP, Obeso JA. SARS-CoV-2 and the risk of Parkinson&#x2019;s disease: facts and fantasy. Lancet Neurol 2021; 20: 94&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834123</ArticleId><ArticleId IdType="pubmed">33253627</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, et al. Persistent clotting protein pathology in long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol 2021; 20: 172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D, Chalon P, Kohn L, et al. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med 2022; 54: 1473&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunez-Castilla J, Stebliankin V, Baral P, et al. Potential autoimmunity resulting from molecular mimicry between SARS-CoV-2 spike and human proteins. Viruses 2022; 14: 1415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9318917</ArticleId><ArticleId IdType="pubmed">35891400</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampogna G, Tessitore N, Bianconi T, et al. Spinal cord dysfunction after COVID-19 infection. Spinal Cord Ser Cases 2020; 6: 92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7525226</ArticleId><ArticleId IdType="pubmed">32999271</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull-Otterson L, Baca S, Saydah S, et al. Post-COVID conditions among adult COVID-19 survivors aged 18&#x2013;64 and &#x2265;65 years&#x2014;United States, March 2020&#x2013;November 2021. MMWR Morb Mortal Wkly Rep 2022; 71: 713&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9368731</ArticleId><ArticleId IdType="pubmed">35925799</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet 2022; 400: 452&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y-H, Chen Y, Wang Q-H, et al. One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: a longitudinal cohort study. JAMA Neurol 2022; 79: 509&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8905512</ArticleId><ArticleId IdType="pubmed">35258587</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021; 38: 101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirin AA. A preliminary estimate of the economic impact of long COVID in the United States. Fatigue 2022; 10: 190&#x2013;199.</Citation></Reference><Reference><Citation>Cutler DM. The costs of long COVID. JAMA Health Forum 2022; 3: e221809.</Citation><ArticleIdList><ArticleId IdType="pubmed">36219031</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Board on the Health of Select Populations, Institute of Medicine. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: redefining an illness. Washington, DC, USA: National Academies Press, 2015.</Citation><ArticleIdList><ArticleId IdType="pubmed">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine RL. Addressing the long-term effects of COVID-19. JAMA 2022; 328: 823&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">35921084</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat Med 2022; 28: 2406&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Al-Aly Z. Risks of mental health outcomes in people with covid-19: cohort study. BMJ 2022; 376: e068993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8847881</ArticleId><ArticleId IdType="pubmed">35172971</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran VT, Porcher R, Pane I, Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat Commun 2022; 13: 1812.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 2020; 19: 919&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon IH, Normandin E, Bhattacharyya S, et al. Neuropathological features of Covid-19. N Engl J Med 2020; 383: 989&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7304421</ArticleId><ArticleId IdType="pubmed">32530583</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deitchman AN, Torres L, et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep 2021; 36: 109518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Lu S, Tang AF, et al. Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis 2021; 224: 1839&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>PHOSP-COVID Collaborative Group. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med 2022; 10: 761&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews MG, Mukhtar T, Eze UC, et al. Tropism of SARS-CoV-2 for human cortical astrocytes. Proc Natl Acad Sci USA 2022; 119: e2122236119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9335272</ArticleId><ArticleId IdType="pubmed">35858406</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M, Morbelli S, Ciccarelli M, et al. Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study. Eur J Nucl Med Mol Imaging 2021; 48: 3187&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7937050</ArticleId><ArticleId IdType="pubmed">33677642</ArticleId></ArticleIdList></Reference><Reference><Citation>Groot C, Risacher SL, Chen JQA, et al. Differential trajectories of hypometabolism across cognitively-defined Alzheimer&#x2019;s disease subgroups. Neuroimage Clin 2021; 31: 102725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8238088</ArticleId><ArticleId IdType="pubmed">34153688</ArticleId></ArticleIdList></Reference><Reference><Citation>Stage EC Jr, Svaldi D, Phillips M, et al. Neurodegenerative changes in early- and late-onset cognitive impairment with and without brain amyloidosis. Alzheimers Res Ther 2020; 12: 93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7409508</ArticleId><ArticleId IdType="pubmed">32758274</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitson HE, Colton C, El Khoury J, et al. Infection and inflammation: new perspectives on Alzheimer&#x2019;s disease. Brain Behav Immun Health 2022; 22: 100462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9475126</ArticleId><ArticleId IdType="pubmed">36118272</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox J, et al. Distinguishing features of long COVID identified through immune profiling. medRxiv 2022; published online Aug 10. 10.1101/2022.08.09.22278592 (preprint).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.09.22278592</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A, Lu P, Geraghty AC, et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell 2022; 185: 2452&#x2013;68.e16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataramani V, Winkler F. Cognitive deficits in long Covid-19. N Engl J Med 2022; 387: 1813&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">36351274</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M, Iwasaki A. The neurobiology of long COVID. Neuron 2022; 110: 3484&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannis D, Allen SL, Tsang J, et al. Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry. Blood 2021; 137: 2838&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8032474</ArticleId><ArticleId IdType="pubmed">33824972</ArticleId></ArticleIdList></Reference><Reference><Citation>Patell R, Bogue T, Koshy A, et al. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood 2020; 136: 1342&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7483433</ArticleId><ArticleId IdType="pubmed">32766883</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasini E, Corsetti G, Romano C, et al. Serum metabolic profile in patients with long-Covid (PASC) syndrome: clinical implications. Front Med (Lausanne) 2021; 8: 714426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339407</ArticleId><ArticleId IdType="pubmed">34368201</ArticleId></ArticleIdList></Reference><Reference><Citation>von Meijenfeldt FA, Havervall S, Adelmeijer J, et al. Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge. Blood Adv 2021; 5: 756&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857699</ArticleId><ArticleId IdType="pubmed">33560386</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhont S, Derom E, Van Braeckel E, Depuydt P, Lambrecht BN. The pathophysiology of happy hypoxemia in COVID-19. Respir Res 2020; 21: 198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385717</ArticleId><ArticleId IdType="pubmed">32723327</ArticleId></ArticleIdList></Reference><Reference><Citation>Thachil J Hypoxia&#x2014;an overlooked trigger for thrombosis in COVID-19 and other critically ill patients. J Thromb Haemost 2020; 18: 3109&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9770767</ArticleId><ArticleId IdType="pubmed">32726507</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang M, Som A, Mendoza DP, et al. Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT. Lancet Infect Dis 2020; 20: 1365&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7252023</ArticleId><ArticleId IdType="pubmed">32359410</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukandala G, Tynan R, Lanigan S, O&#x2019;Connor JJ. The effects of hypoxia and inflammation on synaptic signaling in the CNS. Brain Sci 2016; 6: 6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4810176</ArticleId><ArticleId IdType="pubmed">26901230</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun BT, Badenes R, Heras La Calle G, et al. Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study. Lancet Respir Med 2021; 9: 239&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832119</ArticleId><ArticleId IdType="pubmed">33428871</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes CG, Mailloux PT, Devlin JW, et al. Dexmedetomidine or propofol for sedation in mechanically ventilated adults with sepsis. N Engl J Med 2021; 384: 1424&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8162695</ArticleId><ArticleId IdType="pubmed">33528922</ArticleId></ArticleIdList></Reference><Reference><Citation>Girard TD, Exline MC, Carson SS, et al. Haloperidol and ziprasidone for treatment of delirium in critical illness. N Engl J Med 2018; 379: 2506&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6364999</ArticleId><ArticleId IdType="pubmed">30346242</ArticleId></ArticleIdList></Reference><Reference><Citation>Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008; 371: 126&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">18191684</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandharipande PP, Girard TD, Jackson JC, et al. Long-term cognitive impairment after critical illness. N Engl J Med 2013; 369: 1306&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3922401</ArticleId><ArticleId IdType="pubmed">24088092</ArticleId></ArticleIdList></Reference><Reference><Citation>Girard TD, Shintani AK, Jackson JC, et al. Risk factors for posttraumatic stress disorder symptoms following critical illness requiring mechanical ventilation: a prospective cohort study. Crit Care 2007; 11: R28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2151865</ArticleId><ArticleId IdType="pubmed">17316452</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones C, Griffiths RD, Humphris G, Skirrow PM. Memory, delusions, and the development of acute posttraumatic stress disorder-related symptoms after intensive care. Crit Care Med 2001; 29: 573&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">11373423</ArticleId></ArticleIdList></Reference><Reference><Citation>Shehabi Y, Chan L, Kadiman S, et al. for the Sedation Practice in Intensive Care Evaluation (SPICE) Study Group investigators. Sedation depth and long-term mortality in mechanically ventilated critically ill adults: a prospective longitudinal multicentre cohort study. Intensive Care Med 2013; 39: 910&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3625407</ArticleId><ArticleId IdType="pubmed">23344834</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, et al. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ 2022; 377: e069676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E, Levi R, Sarti R, et al. Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA 2022; 328: 676&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. EClinicalMedicine 2022; 53: 101624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Anglin K, Durstenfeld MS, et al. Effect of oral nirmatrelvir on long COVID symptoms: 4 cases and rationale for systematic studies. Pathog Immun 2022; 7: 95&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9254867</ArticleId><ArticleId IdType="pubmed">35800257</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Choi T, Al-Aly Z. Nirmatrelvir and the risk of post-acute sequelae of COVID-19. medRxiv 2022; published online Nov 5. 10.1101/2022.11.03.22281783 (preprint).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.11.03.22281783</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health. Coronavirus disease 2019 (COVID-19) treatment guidelines. 2023. https://www.covid19treatmentguidelines.nih.gov/ (accessed July 1, 2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">34003615</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhazzani W, M&#xf8;ller MH, Arabi YM, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 2020; 46: 854&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7101866</ArticleId><ArticleId IdType="pubmed">32222812</ArticleId></ArticleIdList></Reference><Reference><Citation>Devlin JW, Skrobik Y, G&#xe9;linas C, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med 2018; 46: e825&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">30113379</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel BK, Wolfe KS, Patel SB, et al. Effect of early mobilisation on long-term cognitive impairment in critical illness in the USA: a randomised controlled trial. Lancet Respir Med 2023; 11: 563&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10238598</ArticleId><ArticleId IdType="pubmed">36693400</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham DM, Davidson J, Cohen H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders&#x2019; conference. Crit Care Med 2012; 40: 502&#x2013;09.</Citation><ArticleIdList><ArticleId IdType="pubmed">21946660</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott D, Davidson JE, Harvey MA, et al. Exploring the scope of post-intensive care syndrome therapy and care: engagement of non-critical care providers and survivors in a second stakeholders meeting. Crit Care Med 2014; 42: 2518&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">25083984</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodgson CL, Higgins AM, Bailey MJ, et al. Comparison of 6-month outcomes of survivors of COVID-19 versus non-COVID-19 critical illness. Am J Respir Crit Care Med 2022; 205: 1159&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9872799</ArticleId><ArticleId IdType="pubmed">35258437</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan E, Beitler JR, Brochard L, et al. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted? Lancet Respir Med 2020; 8: 816&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7338016</ArticleId><ArticleId IdType="pubmed">32645311</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun BT, Balas MC, Barnes-Daly MA, et al. Caring for critically ill patients with the ABCDEF bundle: results of the ICU Liberation Collaborative in over 15,000 adults. Crit Care Med 2019; 47: 3&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6298815</ArticleId><ArticleId IdType="pubmed">30339549</ArticleId></ArticleIdList></Reference><Reference><Citation>Payen JF, Bosson JL, Chanques G, Mantz J, Labarere J, DOLOREA Investigators. Pain assessment is associated with decreased duration of mechanical ventilation in the intensive care unit: a post hoc analysis of the DOLOREA study. Anesthesiology 2009; 111: 1308&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">19934877</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe9;linas C, Fillion L, Puntillo KA, Viens C, Fortier M. Validation of the critical-care pain observation tool in adult patients. Am J Crit Care 2006; 15: 420&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">16823021</ArticleId></ArticleIdList></Reference><Reference><Citation>Payen JF, Bru O, Bosson JL, et al. Assessing pain in critically ill sedated patients by using a behavioral pain scale. Crit Care Med 2001; 29: 2258&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">11801819</ArticleId></ArticleIdList></Reference><Reference><Citation>Str&#xf8;m T, Martinussen T, Toft P. A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial. Lancet 2010; 375: 475&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">20116842</ArticleId></ArticleIdList></Reference><Reference><Citation>Shehabi Y, Howe BD, Bellomo R, et al., for the ANZICS Clinical Trials Group and the SPICE III Investigators. Early sedation with dexmedetomidine in critically ill patients. N Engl J Med 2019; 380: 2506&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">31112380</ArticleId></ArticleIdList></Reference><Reference><Citation>Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 2001; 286: 2703&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">11730446</ArticleId></ArticleIdList></Reference><Reference><Citation>Ely EW, Margolin R, Francis J, et al. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med 2001; 29: 1370&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">11445689</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med 2001; 27: 859&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">11430542</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Boogaard M, Slooter AJC, Br&#xfc;ggemann RJM, et al. Effect of haloperidol on survival among critically ill adults with a high risk of delirium: the REDUCE randomized clinical trial. JAMA 2018; 319: 680&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5839284</ArticleId><ArticleId IdType="pubmed">29466591</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009; 373: 1874&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9906655</ArticleId><ArticleId IdType="pubmed">19446324</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaller SJ, Anstey M, Blobner M, et al. Early, goal-directed mobilisation in the surgical intensive care unit: a randomised controlled trial. Lancet 2016; 388: 1377&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">27707496</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa RG, Falavigna M, da Silva DB, et al. Effect of flexible family visitation on delirium among patients in the intensive care unit: the ICU Visits randomized clinical trial. JAMA 2019; 322: 216&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6635909</ArticleId><ArticleId IdType="pubmed">31310297</ArticleId></ArticleIdList></Reference><Reference><Citation>Marconi VC, Ramanan AV, de Bono S, et al., for the COV-BARRIER Study Group. Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial. Lancet Respir Med 2021; 9: 1407&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409066</ArticleId><ArticleId IdType="pubmed">34480861</ArticleId></ArticleIdList></Reference><Reference><Citation>Ely EW, Ramanan AV, Kartman CE, et al., for the COV-BARRIER Study Group. Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial. Lancet Respir Med 2022; 10: 327&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8813065</ArticleId><ArticleId IdType="pubmed">35123660</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronte V, Ugel S, Tinazzi E, et al. Baricitinib restrains the immune dysregulation in patients with severe COVID-19. J Clin Invest 2020; 130: 6409&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8016181</ArticleId><ArticleId IdType="pubmed">32809969</ArticleId></ArticleIdList></Reference><Reference><Citation>Marconi VC, Moser C, Gavegnano C, et al. Randomized trial of ruxolitinib in antiretroviral-treated adults with human immunodeficiency virus. Clin Infect Dis 2022; 74: 95&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8752257</ArticleId><ArticleId IdType="pubmed">33693561</ArticleId></ArticleIdList></Reference><Reference><Citation>Haile WB, Gavegnano C, Tao S, Jiang Y, Schinazi RF, Tyor WR. The Janus kinase inhibitor ruxolitinib reduces HIV replication in human macrophages and ameliorates HIV encephalitis in a murine model. Neurobiol Dis 2016; 92: 137&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4907871</ArticleId><ArticleId IdType="pubmed">26851503</ArticleId></ArticleIdList></Reference><Reference><Citation>Lashgari NA, Roudsari NM, Momtaz S, Sathyapalan T, Abdolghaffari AH, Sahebkar A. The involvement of JAK/STAT signaling pathway in the treatment of Parkinson&#x2019;s disease. J Neuroimmunol 2021; 361: 577758.</Citation><ArticleIdList><ArticleId IdType="pubmed">34739911</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavegnano C, Haile WB, Hurwitz S, et al. Baricitinib reverses HIV-associated neurocognitive disorders in a SCID mouse model and reservoir seeding in vitro. J Neuroinflammation 2019; 16: 182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6764124</ArticleId><ArticleId IdType="pubmed">31561750</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>